InvestorsHub Logo
Followers 48
Posts 4486
Boards Moderated 0
Alias Born 09/01/2017

Re: georgebailey post# 574358

Wednesday, 03/08/2023 3:09:55 PM

Wednesday, March 08, 2023 3:09:55 PM

Post# of 720481
Not selling to a BP has key advantages:

Not dependent on BP follow through which may be tainted by maximizing existing drugs at expense of dcvax

Not limiting to collaborating with others

Maximizes Nwbo potential to partner, license, and go solo in cases

Maximizes ongoing patent revenue stream

The biggest advantage is not ceding control to BPs that are going to optimize their oncology products and possibly mold immunotherapy into another pay until you pass away treatment. Not having the same values as an nwbo/LP/LL in providing what’s best to fight cancer and extend lives with QoL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News